nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...
Women taking pill may be less likely to suffer ACL injury, study finds
The Guardian, Fri 3 May 2019 09.01 AESTLast modified on Fri 3 May 2019 09.50 AEST Women on the combined pill appear to be less likely to tear a key ligament in their knee, research suggests. Tears to the ACL are known to be more common in women than men, with previous research suggesting fluctuations in hormones during the menstrual cycle, including oestrogen, might play a role by increasing the...
SHINE SA Media Release: Response to the call to ban Diane-35
SHINE SA, issued 13th December 2017 SHINE SA believes everyone should have access to contraceptive choices, and that decisions about contraception are best made in conjunction with a healthcare professional. Cyproterone acetate pills, commonly known as Diane-35 appear to be associated with a higher risk of deep venous thrombosis (DVT) than levonorgestrel (LNG) containing pills, although the...
Rescheduling of ulipristal acetate (EllaOne®) in Australia
SHine SA, October 2016 SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia. The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017. This is an...
Window of vulnerability for STIs to infect human female reproductive tract
Science Daily, March 16, 2015
A comprehensive review of the role of sex hormones in the geography of the female reproductive tract has been presented by researchers, with evidence supporting a “window of vulnerability” to HIV and other sexually transmitted infections (STIs).
Read more here
Oral contraceptive use and mortality
ABC Health Report, Monday 2 February 2015 5:53PM Researchers from Boston have followed 120,000 female nurses for around 40 years, looking at their health and wellbeing, including their contraception and comparing that to cause and age at death. They wanted to find out whether oral contraceptive use is associated with total and cause specific mortality. Read transcript here Listen online here...